Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

BioBrace® Augmentation in Anterior Cruciate Ligament Reconstruction Procedures

NCT: NCT06948591 · RECRUITING

NCT IDNCT06948591
StatusRECRUITING
Start Date2025-04-08
Completion2030-06

Brief Summary

This research study will evaluate mid-term clinical safety and performance outcomes of the BioBrace® Reinforced Implant when used to augment a tissue graft during anterior cruciate ligament (ACL) reconstruction.

Frequently Asked Questions

What is BioBrace® Augmentation in Anterior Cruciate Ligament Reconstruction Procedures?

BioBrace® Augmentation in Anterior Cruciate Ligament Reconstruction Procedures is a clinical trial registered under NCT06948591. Current status: RECRUITING.

What is the status of NCT06948591?

The current status of NCT06948591 (BioBrace® Augmentation in Anterior Cruciate Ligament Reconstruction Procedures) is: RECRUITING.

When did BioBrace® Augmentation in Anterior Cruciate Ligament Reconstruction Procedures start?

BioBrace® Augmentation in Anterior Cruciate Ligament Reconstruction Procedures started on 2025-04-08.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑